Two unrelated cases with biallelic variants of CHEK2: a new condition with constitutional chromosomal instability? – European Journal of Human Genetics

Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, et al. CHEK2 germline variants in cancer susceptibility: dead end rather than checkmate. Cells. 2020;9:2675.

Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT, et al. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol. 2004;24:708–18.

CAS Google Scholar Article

Paperna T, Sharon-Shwartzman N, Kurolap A, Goldberg Y, Moustafa N, Carasso Y, et al. Homozygosity for CHEK2 p.Gly167Arg leads to a single cancer syndrome with multiple complex chromosomal translocations in the peripheral blood karyotype. J Med Genet. 2020;57:500–4.

CAS Google Scholar Article

Kukita Y, Okami J, Yoneda-Kato N, Nakamae I, Kawabata T, Higashiyama M, et al. Homozygous inactivation of CHEK2 is linked to a familial case of multiple primary lung cancer accompanied by cancers in other organs. Case Stud Cold Spring Harb Mol. 2016;2:a001032.

Google Scholar article

van Puijenbroek M, van Asperen CJ, van Mil A, Develee P, van Wezel T, Morreau H. Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype. J Pathol. 2005;206:198–204.

Google Scholar article

Janiszewska H, ​​Bak A, Skonieczka K, Jaskowiec A, Kielbinski M, Jachalska A, et al. Constitutional mutations in the CHEK2 gene are a risk factor for MDS, but not for de novo AML. Leuk Res. 2018;70:74–8.

CAS Google Scholar Article

Kaczmarek-Rys M, Ziemnicka K, Hryhorowicz ST, Gorczak K, Hoppe-Golebiewska J, Skrzypczak-Zielinska M, et al. The c.470 T>C CHEK2 missense variant increases the risk of differentiated thyroid carcinoma in the Greater Poland population. Hered Cancer Clin Prof. 2015;13:8.

Google Scholar article

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and Guidelines for Sequence Variant Interpretation: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

Google Scholar article

Agiannitopoulos K, Papadopoulou E, Tsaousis GN, Pepe G, Kampouri S, Kocdor MA, et al. Characterization of c.793-1G > A splice variant of the CHEK2 gene as a pathogen: about a case. BMC Med Genet. 2019;20:131.

Google Scholar article

Adank MA, Jonker MA, Kluijt I, van Mil SE, Oldenburg RA, Mooi WJ, et al. CHEK2*1100delC homozygosity is associated with an elevated risk of breast cancer in women. J Med Genet. 2011;48:860–3.

CAS Google Scholar Article

Stradella A, Del Valle J, Rofes P, Feliubadalo L, Grau Garces E, Velasco A, et al. Does the multilocus hereditary neoplasia allele syndrome have a severe clinical expression? J Med Genet. 2019;56:521–5.

CAS Google Scholar Article

Sutcliffe EG, Stettner AR, Miller SA, Solomon SR, Marshall ML, Roberts ME, et al. Differences in cancer prevalence among CHEK2 carriers identified by multigene panel testing. Cancer Genet. 2020; 246-7: 12–7.

Google Scholar article

Graffeo R, Rana HQ, Conforti F, Bonanni B, Cardoso MJ, Paluch-Shimon S, et al. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D. Breast. 2022;65:32–40.

CAS Google Scholar Article

Yang HW, Kim TM, Song SS, Shrinath N, Park R, Kalamarides M, et al. Alternative splicing of CHEK2 and co-deletion with NF2 promotes chromosomal instability in meningioma. Neoplasia. 2012;14:20–8.

CAS Google Scholar Article

Xie L, Zhao T, Cai J, Su Y, Wang Z, Dong W. Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells. Onco targets Ther. 2016;9:7115–22.

CAS Google Scholar Article

Delimitsou A, Fostira F, Kalfakakou D, Apostolou P, Konstantopoulou I, Kroupis C, et al. Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system. Hum Mutat. 2019;40:631–48.

CAS Google Scholar Article

Oh JM, Myung K. Crosstalk between different DNA repair pathways for DNA double-strand break repairs. Mutat Res Genet Toxicol Environ Mutagen. 2022;873:503438.

CAS Google Scholar Article

Rodgers K, McVey M. Error-prone repair of DNA double-strand breaks. J Cell Physiol. 2016;231:15–24.

CAS Google Scholar Article

Scully R, Panday A, Elango R, Willis NA. Choice of DNA double-strand break repair pathway in mammalian somatic cells. Nat Rev Mol Cell Biol. 2019;20:698–714.

CAS Google Scholar Article

Taylor AMR, Rothblum-Oviatt C, Ellis NA, Hickson ID, Meyer S, Crawford TO, et al. Chromosomal instability syndromes. Nat Rev Dis Prim. 2019;5:64.

Google Scholar article

Bahassi el M, Robbins SB, Yin M, Boivin GP, ​​Kuiper R, van Steeg H, et al. Mice with the CHEK2*1100delC SNP are predisposed to cancer with a strong gender bias. Proc Natl Acad Sci USA. 2009;106:17111–6.

Google Scholar article

Huijts PE, Hollestelle A, Balliu B, Houwing-Duistermaat JJ, Meijers CM, Blom JC, and others CHEK2*1100delC homozygosity in the Netherlands-prevalence and risk of breast and lung cancer. Eur J Hum Genet. 2014;22:46–51.

CAS Google Scholar Article

Rainville I, Hatcher S, Rosenthal E, Larson K, Bernhisel R, Meek S, et al. High risk of breast cancer in women with pathogenic biallelic variants in CHEK2. Breast Cancer Treatment Res. 2020;180:503–9.

CAS Google Scholar Article